Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-038868

Options or other derivatives

  • Director acquired 26,025 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MESSEMER DEBORAH M. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-06 Grant or award : show line 1 in the form Stock Option (Right to Buy) +26,025 26,025 D
Loading xslF345X03/doc4.xml…